Penbrook Management LLC - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 871 filers reported holding NOVARTIS A G in Q3 2014. The put-call ratio across all filers is 0.59 and the average weighting 0.6%.

Quarter-by-quarter ownership
Penbrook Management LLC ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$556,156
+0.9%
5,4600.0%0.41%
+2.3%
Q2 2023$550,969
+9.7%
5,4600.0%0.40%
+3.6%
Q1 2023$502,320
+1.4%
5,4600.0%0.38%
-8.8%
Q4 2022$495,331
+0.9%
5,460
-15.5%
0.42%
-0.2%
Q3 2022$491,000
-10.1%
6,4600.0%0.42%
-1.9%
Q2 2022$546,000
-3.7%
6,4600.0%0.43%
+17.1%
Q1 2022$567,000
+0.4%
6,4600.0%0.37%
+8.2%
Q4 2021$565,000
+7.0%
6,4600.0%0.34%
+3.7%
Q3 2021$528,000
-10.4%
6,4600.0%0.33%
-7.1%
Q2 2021$589,000
+6.7%
6,4600.0%0.35%
-11.1%
Q1 2021$552,000
-13.5%
6,460
-4.4%
0.40%
-19.1%
Q4 2020$638,000
+8.5%
6,7600.0%0.49%
-3.7%
Q3 2020$588,000
-0.3%
6,7600.0%0.51%
-12.1%
Q2 2020$590,000
+5.9%
6,7600.0%0.58%
-18.7%
Q1 2020$557,000
-13.0%
6,7600.0%0.71%
+14.3%
Q4 2019$640,000
+9.0%
6,7600.0%0.62%
-2.0%
Q3 2019$587,000
-1.2%
6,760
+4.0%
0.64%0.0%
Q2 2019$594,000
+12.3%
6,500
+18.2%
0.64%
+15.8%
Q1 2019$529,000
+12.1%
5,5000.0%0.55%
+2.0%
Q4 2018$472,000
-0.4%
5,5000.0%0.54%
+18.7%
Q3 2018$474,000
+14.2%
5,5000.0%0.45%
+13.8%
Q2 2018$415,000
-6.7%
5,5000.0%0.40%
-10.3%
Q1 2018$445,000
-3.7%
5,5000.0%0.44%
+7.0%
Q4 2017$462,000
+6.5%
5,5000.0%0.42%
-11.1%
Q3 2016$434,000
-4.4%
5,5000.0%0.47%
-6.6%
Q2 2016$454,000
+14.1%
5,5000.0%0.50%
+14.4%
Q1 2016$398,000
-15.9%
5,5000.0%0.44%
-9.7%
Q4 2015$473,000
-6.5%
5,5000.0%0.48%
-9.5%
Q3 2015$506,000
-6.5%
5,5000.0%0.54%
+4.3%
Q2 2015$541,000
+5.5%
5,500
+5.8%
0.51%
+12.7%
Q1 2015$513,000
+6.4%
5,2000.0%0.46%
+4.8%
Q4 2014$482,000
-1.4%
5,2000.0%0.44%
-3.5%
Q3 2014$489,000
+3.8%
5,2000.0%0.45%
+8.4%
Q2 2014$471,000
-45.2%
5,200
-50.0%
0.42%
+1.0%
Q1 2014$860,000
+105.7%
10,400
+100.0%
0.41%
+1.5%
Q4 2013$418,0005,2000.41%
Other shareholders
NOVARTIS A G shareholders Q3 2014
NameSharesValueWeighting ↓
Martin Investment Management, LLC 229,184$23,344,6827.00%
Foresight Global Investors, Inc. 97,500$9,397,7375.23%
SCHARF INVESTMENTS, LLC 1,425,745$145,226,3224.34%
MANAGED ASSET PORTFOLIOS, LLC 274,204$27,930,3694.28%
GARLAND CAPITAL MANAGEMENT INC 54,710$5,572,7613.93%
PRENTISS SMITH & CO INC 52,032$5,299,9803.91%
WILKINS INVESTMENT COUNSEL INC 130,950$13,3393.61%
First Fiduciary Investment Counsel, Inc. 145,731$14,8443.48%
Cullen Capital Management, LLC 2,714,809$276,530,4643.23%
JOHN G ULLMAN & ASSOCIATES INC 182,690$18,608,8033.04%
View complete list of NOVARTIS A G shareholders